Serum lncRNA-ANRIL and SOX9 expression levels in glioma patients and their relationship with poor prognosis

Abstract Background lncRNA-CDKN2B antisense RNA 1 (ANRIL) and SRY-box transcription factor 9 (SOX9) has abnormal expression in many tumors including glioma, but the underlying molecular mechanism is unclear. This study set out to investigate the serum lncRNA-ANRIL and SOX9 levels in glioma patients...

Full description

Bibliographic Details
Main Authors: Youlu Sun, Yuesong Jing, Yuxin Zhang
Format: Article
Language:English
Published: BMC 2021-09-01
Series:World Journal of Surgical Oncology
Subjects:
Online Access:https://doi.org/10.1186/s12957-021-02392-2